Table 1.
Clinical characteristics of the patients according to systolic heart function.
| With LVSD | Without LVSD | P | |
|---|---|---|---|
| N | 356 | 404 | |
| Age (yrs) | 66 ± 14 | 63 ± 12 | .17 |
| Male sex (%) | 80 | 78 | .58 |
| BMI (Kg/m2) | 27.5 ± 4 | 28 ± 5 | .14 |
| Systolic blood pressure at entry | 128.6 ± 29.2 | 133.6 ± 26 | .013 |
| Diastolic blood pressure at entry | 75.5 ± 14 | 77.4 ± 13 | .05 |
| Heart rate at entry | 81 ± 16 | 79 ± 16 | .71 |
| Diagnosis MI (%) | 84 | 71 | <.0001 |
| Number of Vessel disease | 2 ± 0.9 | 1.8 ± 0.9 | <.0001 |
| Previous CHD (%) | 49 | 47 | .62 |
| Time delay (min) | 548 ± 1953 | 651 ± 2702 | .65 |
| Troponin I at entry | 40.28 ± 72.77 | 16.74 ± 39.43 | <.0001 |
| Uric acid (mg/dL) | 6.69 ± 2.15 | 6.14 ± 2.02 | <.0001 |
| Blood glucose at entry (mg/dL) | 166 ± 89 | 151 ± 82 | .01 |
| CRP (mg/L) | 43.63 ± 52.97 | 26.9 ± 42 | <.0001 |
| WBC count | 11123 ± 10726 | 9856 ± 5180 | .05 |
| Creat clear (mL/min) | 72 ± 34 | 78 ± 32 | .01 |
| Ht (%) | 41.4 ± 5.4 | 41.4 ± 5.0 | .93 |
| LDL (mg/dL) | 125.36 ± 46.33 | 127.23 ± 44.6 | .59 |
| Prior statin therapy (% hyperlipidemics) | 44 | 42 | .21 |
| Current smoking % | 49 | 47 | .49 |
| Physical activity (%) | 58 | 66 | .30 |
| Hypertension (%) | 59 | 62 | .36 |
| Receiving medication for hypertension (%) | 41 | 49 | .32 |
| Diabetes mellitus (%) | 36 | 30 | .13 |
| Receiving oral medication for diabetes mellitus (%) | 31 | 36 | .08 |
| Insulin therapy (%) | 30 | 33 | .18 |
LVSD indicates left ventricular systolic dysfunction; BMI indicates body mass index; Ht indicates hematocrit; Time delay = time in minutes from symptoms onset till hospitalization; Previous CHD: previous known coronary heart disease.